Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from TOT BIOPHARM International Co. Ltd. ( (HK:1875) ).
TOT BIOPHARM International Co. Ltd. has announced a change in the composition of its board committee. Dr. Liu, Weidong, who was previously the chairperson of the Remuneration Committee, has been replaced by Mr. Zhang, Qing, an independent non-executive director, to comply with the Listing Rules of the Hong Kong Stock Exchange. This change is effective from March 21, 2025, and aims to ensure the company meets regulatory requirements, potentially impacting its governance structure and investor confidence.
More about TOT BIOPHARM International Co. Ltd.
YTD Price Performance: 13.41%
Average Trading Volume: 152,560
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$1.61B
See more insights into 1875 stock on TipRanks’ Stock Analysis page.